Delivery Order SPE2DB22D3004-SPE2DB24FQT38
- Not listed
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FB6V7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,165.20, is a Delivery Order for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 9, 2024. This award is not designated as a set-aside contract....
- This federal contract award, valued at $1,513.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical commodity with a completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as...
- This federal contract award, identified as SPE2DB22D1052|SPE2DB24FU9CL, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,052.58. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 24, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order worth $1,417.60 for the procurement of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 9, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB21FK5G9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,531.70 firm fixed-price delivery order is for the medical product GADAVIST 10 MMOL/10 ML VIAL 10ML. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.87 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,216.74, is a firm fixed-price delivery order for the supply of GADAVIST 7.5 MMOL/7.5 ML SYR 7.5ML, a medical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,274.88, for the supply of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. The contract has an Ultimate Completion Date of April 1, 2025 and was awarded on March 31, 2025. This award is not a set-aside contract....
- This federal contract award to Amerisourcebergen Drug Corp is for the provision of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a pharmaceutical product. The $1,456.20 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,834.97 firm fixed-price delivery order is for Gadavist 10 mmol/10 ml vials. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQT38Delivery Order
This federal contract award, SPE2DB22D3004|SPE2DB24FQT38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $7,430.26, is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract does not have a set-aside designation, indicating it was open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to various federal government agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation. The contract is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is June 17, 2024. Amerisourcebergen Drug Corp is also the holder of a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 6/14/24 |